Biotech QiLu Pharmaceutical’s Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation August 18, 2023
Biotech Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements. August 18, 2023
Biotech I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates August 17, 2023
Biotech Esophageal Cancer Market and Epidemiology Insights 2023-2032: Potential Drugs Zanidatamab, Sintilimab, Tislelizumab, and Sotigalimab Expected to Significantly Impact the Market August 17, 2023
Biotech AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults August 17, 2023
Biotech IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma August 16, 2023
Biotech BRAF-Mutant Metastatic Melanoma in 7MM, 2023-2032: Unveiling the Emerging Drugs, Therapies, and Unmet Needs August 16, 2023
Search
Biotech
August 18, 2023
August 18, 2023
August 18, 2023
August 18, 2023
August 17, 2023
August 17, 2023
August 17, 2023
August 17, 2023
August 16, 2023
August 16, 2023
